Sign In

Michael Ciesielski

CEO / MimiVax, LLC

Michael Ciesielski is a highly accomplished individual with a strong background in immunology and biotechnology.

He holds a Doctor of Philosophy (PhD) degree in Immunology from the University at Buffalo, a Master of Science (MS) degree in Natural Sciences from the University at Buffalo, and a Bachelor of Science (BS) degree in Biotechnology from Niagara University.

With a passion for disrupting cancer and improving patient outcomes, Michael is currently the Chief Executive Officer at MimiVax, LLC.

Prior to his current role, he served as the Chief Scientific Officer at MimiVax, LLC, where he focused on developing highly innovative immunotherapies.

Michael Ciesielski's academic and professional journey also includes a position as an Assistant Professor at the renowned Roswell Park Cancer Institute.

His dedication to advancing immunotherapy and enhancing patient survival underscores his commitment to making a significant impact in the field of cancer research.

Highlights

Jun 26 · linkedin

Learn about #SurVaxM and #GBM at www.mimivax.com & check out our new animated mechanism of action video below. MimiVax, Inc. Sheila Figel

Jun 21 · linkedin

“Roswell Park and all of Western New York have so much reason to be proud of SurVaxM and the team behind it,” says Roswell Park President and CEO Candace S. Johnson, PhD. “SurVaxM is one of the few treatment options for incurable brain cancer to reach late-stage clinical trials, and everyone who supports this work is helping to speed a highly promising cancer treatment to patients who may benefit from it.”

Michael Ciesielski
Add to my network

Location

Buffalo/Niagara, New York Area